Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays
- PMID: 38700721
- DOI: 10.1097/MBC.0000000000001305
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays
Abstract
Background: Predicting the bleeding risk in hemophilia A and B carriers (HAC, HBC) is challenging.
Objective: The objectives of this study were to describe the bleeding phenotype in HAC and HBC using the standardized Tosetto bleeding score (BS); to determine whether the BS correlates better with factor levels measured with a chromogenic assay than with factor levels measured with chronometric and thrombin generation assays; and to compare the results in HAC and HBC.
Methods: This ambispective, noninterventional study included obligate and sporadic HAC and HBC followed at a hemophilia treatment center between 1995 and 2019.
Results and conclusion: The median BS (3, range 0-21 vs. 3.5, range 0-15, P = ns, respectively) and the abnormal BS rate (35.6% vs. 38.2%, P = ns) were not significantly different in 104 HAC and 34 HBC (mean age: 38 years, 6-80 years). However, some differences were identified. The risk of factor deficiency was higher in HBC than HAC. Specifically, Factor VIII activity (FVIII):C/Factor IX activity (FIX):C level was low (<40 IU/dl) in 18.3% (chronometric assay) and 17.5% (chromogenic assay) of HAC and in 47% and 72.2% of HBC ( P < 0.001). Moreover, the FIX:C level thresholds of 39.5 IU/dl (chronometric assay) and of 33.5 IU/dl (chromogenic assay) were associated with very good sensitivity (92% and 100%, respectively) and specificity (80% for both) for bleeding risk prediction in HBC. Conversely, no FVIII:C level threshold could be identified for HAC, probably due to FVIII:C level variations throughout life.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Hermans C, Kulkarni R. Women with bleeding disorders. Haemophilia 2018; 24:29–36.
-
- Van Galen KPM, d’Oiron R, James P, Abdul-Kadir R, Kouides PA, Kulkarni R, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19:1883–1887.
-
- Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AHJT, Ploos Van Amstel HK, Van Der Bom JG, Van Diemen-Homan JEM, et al. Bleeding in carriers of haemophilia. Blood 2006; 108:52–56.
-
- Labarque V, Perinparajah V, Bouskill V, Stain AM, Wakefield C, Manuel C, et al. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A. Am J Hematol 2017; 92:E94–E96.
-
- Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A. Severe and moderate haemophilia A and B in US females. Haemophilia 2014; 20:e136–e143.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
